Table 1.
Clinical features of the sample and baseline differences between treatment groups.
Table 2.
Changes in clinical variables between admission (T0) and discharge (T1) amongst groups of treatment.
Table 3.
Changes in anxiety, depression, social anxiety and eating preoccupations/rituals as measured with semi-structured interviews between admission (T0) and discharge (T1) amongst groups of treatment.
Fig 1.
Changes in Yale-Brown-Cornell Eating Disorders Scale (YBC-EDS) total score (1a) and preoccupations (1b) and rituals (1c) subscales amongst groups of treatment at admission (T0) and discharge (T1).
All groups significantly improved on all YBC-EDS scales but those patients undergoing aripiprazole in combination with Selective Serotonin Reuptake Inhibitors (SSRIs) reported a significantly larger improvement when compared to the other groups. Mean scores and 95% confidence intervals are shown as columns and bars, respectively.